Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 4
1968 8
1969 6
1970 8
1971 4
1972 8
1973 6
1974 18
1975 10
1976 9
1977 8
1978 5
1979 5
1980 9
1981 20
1982 37
1983 14
1984 14
1985 18
1986 10
1987 21
1988 37
1989 29
1990 47
1991 42
1992 47
1993 36
1994 53
1995 203
1996 476
1997 506
1998 613
1999 605
2000 631
2001 651
2002 787
2003 839
2004 914
2005 898
2006 951
2007 1002
2008 1097
2009 1074
2010 1293
2011 1649
2012 1810
2013 1508
2014 1302
2015 1467
2016 1366
2017 1296
2018 1353
2019 461
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

23,391 results
Results by year
Filters applied: . Clear all
Page 1
Designing and developing suppository formulations for anti-HIV drug delivery
Ham AS and Buckheit RW. Ther Deliv 2017 - Review. PMID 28825395 Free PMC article.
Therefore, virtually no rational pharmaceutical development of antiviral suppositories has been performed. However, suppositories offer several advantages over other antiviral dosage forms. ...
Therefore, virtually no rational pharmaceutical development of antiviral suppositories has been performed. However, suppositories off …
Implementation challenges for long-acting antivirals as treatment
Havlir D and Gandhi M. Curr Opin HIV AIDS 2015 - Review. PMID 26049955 Free PMC article.
Current knowledge gaps in the use of these agents remain, leading to multiple anticipated systems-level and individual-level barriers to implementation. Addressing these gaps and barriers will help fulfill the promise of these agents against the pandemic....
Current knowledge gaps in the use of these agents remain, leading to multiple anticipated systems-level and individual-level barriers …
Past, Present, and Future Drug Delivery Systems for Antiretrovirals
Kirtane AR, et al. J Pharm Sci 2016 - Review. PMID 27771050
This has prompted the development of alternate dosage forms such as vaginal rings and long-acting injectables that stand to improve patient adherence. ...
This has prompted the development of alternate dosage forms such as vaginal rings and long-acting injectables that stand to improve p …
[HIV infection : Test and treatment]
Rockstroh JK and Wasmuth JC. Internist (Berl) 2016 - Review. PMID 27368530 German.
Formulation and delivery of anti-HIV rectal microbicides: advances and challenges
Nunes R, et al. J Control Release 2014 - Review. PMID 25229988
Desirable rectal microbicide product features regarding characteristics such as pH, osmolality, excipients, dosage forms, volume to be administered and the need for applicator use have been studied and defined in recent years, and specific guidance is now possible. ...
Desirable rectal microbicide product features regarding characteristics such as pH, osmolality, excipients, dosage forms, volume to b …
Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates
Herrera C, et al. AIDS 2016. PMID 26854808 Free article.
METHODS: Indicator cells, cocultures of immature dendritic cells with CD4T cells, and colorectal tissue explants were used to assess antiviral activity of drug combinations. ...An initial gel-formulation of MVC-DPV combination showed greater and prolonged antiviral activity of MVC in mucosal tissue explants. ...
METHODS: Indicator cells, cocultures of immature dendritic cells with CD4T cells, and colorectal tissue explants were used to assess anti
23,391 results
Jump to page
Feedback